0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-41.24%
Revenue decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine competitive position erosion.
-37.57%
Cost reduction while ECL.AX shows 0.00% growth. Joel Greenblatt would examine competitive advantage.
-44.89%
Gross profit decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine competitive position.
-6.22%
Margin decline while ECL.AX shows 0.00% expansion. Joel Greenblatt would examine competitive position.
-100.00%
R&D reduction while ECL.AX shows 0.00% growth. Joel Greenblatt would examine competitive risk.
30.99%
G&A change of 30.99% while ECL.AX maintains overhead. Bruce Berkowitz would investigate efficiency.
-21.62%
Marketing expense reduction while ECL.AX shows 0.00% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
-18.65%
Operating expenses reduction while ECL.AX shows 0.00% growth. Joel Greenblatt would examine advantage.
-30.35%
Total costs reduction while ECL.AX shows 0.00% growth. Joel Greenblatt would examine advantage.
-100.00%
Interest expense reduction while ECL.AX shows 0.00% growth. Joel Greenblatt would examine advantage.
91.33%
D&A change of 91.33% while ECL.AX maintains D&A. Bruce Berkowitz would investigate efficiency.
-59.47%
EBITDA decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
-31.02%
EBITDA margin decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
-86.49%
Operating income decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
-77.00%
Operating margin decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
134.95%
Other expenses change of 134.95% while ECL.AX maintains costs. Bruce Berkowitz would investigate control.
-74.45%
Pre-tax income decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
-56.52%
Pre-tax margin decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
6.31%
Tax expense change of 6.31% while ECL.AX maintains burden. Bruce Berkowitz would investigate strategy.
-69.08%
Net income decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
-47.38%
Net margin decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
-70.00%
EPS decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
-70.00%
Diluted EPS decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
0.93%
Share count change of 0.93% while ECL.AX is stable. Bruce Berkowitz would verify approach.
-2.64%
Diluted share reduction while ECL.AX shows 0.00% change. Joel Greenblatt would examine strategy.